The lived-experience reviewer
Does the workflow respect the practical reality of MDI?
Bolus Master is entering a small, invitation-only review focused on the MDI use case, usability, calculation transparency, data integrity, privacy, and places where the product could be misunderstood.
Early products often fail quietly: a label is misunderstood, a setting is easy to overlook, a record is hard to find, or a reassuring sentence says more than the software can support. A reviewer who pauses, questions, and explains what they expected can help us find those problems before the cohort grows.
Does the workflow respect the practical reality of MDI?
Can a new person explain what the product does, what it records, and what it does not know?
Are privacy, access, data integrity, and safety boundaries visible and believable?
The first cohort will remain deliberately small so each observation can be followed up and early issues can be addressed responsibly.
Clarity, burden, real-world language, and moments where the workflow does not match lived experience.
Clinical communication, foreseeable misunderstanding, educational boundaries, and safety escalation.
Usability, accessibility, onboarding, information hierarchy, and product positioning.
Data minimization, account boundaries, integrations, access controls, and incident handling.
Reviewers receive a consistent agenda and sample workflows so feedback can be compared and prioritized.
Can the reviewer accurately explain what the app does and does not do?
Are settings, context, IOB handling, and the final breakdown understandable?
Do optional timing and context tools behave intentionally without creating stale state?
Do recorded actions remain accurate, findable, and consistent across signed-in devices?
Where could language or behavior create a false assumption?
The review is structured so participants can focus on what they noticed rather than trying to cover every feature.
Read the purpose and safety boundary.
Follow one fictional or retrospective workflow from input to later review.
Identify anything confusing, overstated, missing, or difficult to verify.
Explain what you expected, what happened, and what should change first.
You are not being asked to change treatment, prove an outcome, or share more health information than the review requires.
Feedback is grouped into four categories: confusion, data integrity, privacy and access, and future ideas. The first three receive priority during controlled review because they can affect whether the product is understood and used responsibly. Feature requests may be recorded without being promised.
The early cohort is small so observations can be reviewed individually. A comment may lead to a wording change, a workflow fix, a new test, a documentation clarification, or a decision not to proceed. Reviewer comments will not be presented as evidence that the product improves clinical outcomes.
Approved reviewers receive a personal, single-use invitation, review the current beta agreement and privacy notice, and receive time-limited account access that can be paused or ended individually. A protected reviewer guide provides the same preparation and evaluation agenda to each participant.
Submitting a request does not create an account or guarantee access.